Biological Intellectual Property Protection Act of 2025

H.R.6624/S.3452 - Biological Intellectual Property Protection Act of 2025

Client expense: Not reported · Firm income: $82,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)

Issues related to tariffs Issues related to trade agreements S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025

Client expense: $2,440,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Federal Trade Commission related issues Issues related to the Patent Act, no specific bill Issues related to March-In/Bayh Dole, WTO/TRIPS Issues related to patent thickets Issues related to obviousness/ double patenting Issues related to FDA/PTO coordination Issues related to skinny labeling S.1041 A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1040 -A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S 708/ HR 1574 -- Realizing Engineering, Science and Technology Opportunities by Restoring Exclusive Patent Rights Act of 2025 (RESTORE) S.1553/HR3160-- Promoting and Respecting Economically Viable American Innovation Act (PREVAIL) S. 1546/ HR 3152-- Patent Eligibility Restoration Act of 2025 (PERA) S 2276 / HR 3269 Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 43/HR 6485 Skinny Labels Big Savings Act S.2658 Medication Affordability and Patent Integrity Act S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025

Client expense: $2,440,000 · Firm income: Not reported

S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues

Client expense: $7,360,000 · Firm income: Not reported

H.R. 1422, Enhanced Iran Sanctions Act, all provisions. H.R. 1800, Solidify Iran Sanctions Act (SISA), all provisions. H.R. 2683, Remote Access Security Act, all provisions. H.R. 3447, Chip Security Act, all provisions. H.R. 425, Repealing Big Brother Overreach Act, all provisions. H.R. 4397, Muslim Brotherhood Terrorist Designation Act of 2025, all provisions. H.R. 4505, Export Controls Enforcement Act, all provisions. H.R. 4530, STOP Shells Act, all provisions. H.R. 4920, BIS IT Modernization Act, all provisions. H.R. 4930, Counterfeit Notification Act, all provisions. H.R. 5490, Dismantle Foreign Scam Syndicates Act, all provisions. H.R. 5853, ECRA Penalty Increase Act, all provisions. H.R. 6058, Semiconductor Technology Resilience, Integrity, and Defense Enhancement (STRIDE) Act, all provisions. H.R. 6322, Stop Stealing Our Chips Act, all provisions. H.R. 6331, Addressing Dangerous Vulnerabilities in Exports and Research to Strategic Adversaries, Regimes, and Industrial Entities of Security Concern (ADVERSARIES) Act, all provisions. H.R. 6624, Biological Intellectual Property Protection Act of 2025, all provisions. H.R. 6875, AI OVERWATCH Act, all provisions. H.R. 6996, Full AI Stack Export Promotion Act, all provisions. H.R. 7003, BIS Strategic Talent Recruitment to Enhance National Guardrails for Technological Handling (STRENGTH) Act, all provisions. H.R. 7184, Preventing Rogue Equipment for Synthetic Substances (PRESS) Act, all provisions. H.R. 7552, CBW Fentanyl Act, all provisions. H.R. 8036, Interagency Coordination in Export Controls Act, all provisions. H.R. 8106, Rosatom Energy Sanctions Compliance and Unified Enforcement (RESCUE) Act, all provisions. H.R. 8169, Export Control Enforcement and Enhancement Act, all provisions. H.R. 8170, Multilateral Alignment of Technology Controls on Hardware (MATCH) Act, all provisions. H.R. 8202, ECRA Statute of Limitations Extension, all provisions. H.R. 8283, Deterring American AI Model Theft Act of 2026, all provisions. H.R. 8284, Bureau of Industry and Security License Administration Enhancement Act, all provisions. S. 1473, Stop Stealing our Chips Act, all provisions. S. 1490, Global Hunt for Offshore Smuggling and Trafficking (GHOST) Act of 2025, all provisions. S. 1705, Chip Security Act, all provisions. S. 1889, Solidify Iran Sanctions Act (SISA), all provisions. S. 2293, Muslim Brotherhood Terrorist Designation Act of 2025, all provisions. S. 2677, Counterfeit Notification Act, all provisions. S. 2904, Sanctioning Harbors and Dodgers of Western Sanctions (SHADOW) Fleets Act, all provisions. S. 3172, A bill to repeal certain Acts that impose sanctions upon Syria, all provisions. S. 3452, Biological Intellectual Property Protection Act of 2025, all provisions. S. 3519, Remote Access Security Act, all provisions. S. 4281, Multilateral Alignment of Technology Controls on Hardware (MATCH) Act, all provisions. S. 4446, Preventing Rogue Equipment for Synthetic Substances (PRESS) Act, all provisions. S. 4456, AI OVERWATCH Act, all provisions. S. 4723, Eliminate PRC Organized Crime Act, all provisions. S. 4835, Bureau of Industry and Security License Administration Enhancement Act, all provisions. S. 556, Enhanced Iran Sanctions Act of 2025, all provisions. S. 63, CBW Fentanyl Act, all provisions. Issues Related to American Economic Statecraft; Anti-Money Laundering and Combating the Financing of Terrorism; Captagon, Fentanyl, and International Narcotics Production and Trafficking; China-Related Tax and Investment Authorities; Chinese Access to U.S. Capital Markets and Advanced Technology; DIB Capacity Tax Incentives; Evaluating Sanctions, Export Controls, and AML Regulations, Regulatory Authorities, and Legislative Authorities; Expansion of CFIUS Authorities; Foreign Investment in Latin America; Hezbollah, Iran, and IRGC Funding Streams; Implementation and Oversight of the Corporate Transparency Act; Implementation and Oversight of the Countering Americas Adversaries Through Sanctions Act (CAATSA); Implementation and Oversight of the Foreign Extortion Prevention Act; Iranian Oil Sanctions Enforcement; Muslim Brotherhood Funding Streams; National Security-Related Foreign Investment Screening Processes for U.S. Allies; Tax-Exempt Status of Organizations with Ties to U.S. Adversaries; U.S. Adversaries Illicit Finance Activities; U.S. Adversaries Sanctions Evasion Schemes; U.S. Anti-Corruption Sanctions and Strategy; U.S. China Sanctions Policy; U.S. Cuba Sanctions Policy; U.S. Export Control Policy; U.S. Houthi Sanctions Policy; U.S. International Sovereign Debt Policy; U.S. Investment Screening and Security; U.S. Iran Sanctions Policy; U.S. Iraq Sanctions Policy; U.S. Muslim Brotherhood Sanctions Policy; U.S. Nicaragua Sanctions Policy; U.S. Oman Sanctions; U.S. Polisario Front Sanctions Policy; U.S. Russia Oil Waivers and Sanctions Policy; U.S. Sanctions Authorities, Implementation, Enforcement, Resourcing, and Policy; U.S. Syria Sanctions Policy; U.S. Terror Finance Policy; and U.S. Turkey Sanctions Policy (no bill).

S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues

Client expense: $890,000 · Firm income: Not reported

H.R.6624/S.3452 - Biological Intellectual Property Protection Act of 2025

Client expense: Not reported · Firm income: $82,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Federal Trade Commission related issues Issues related to the Patent Act, no specific bill Issues related to March-In/Bayh Dole, WTO/TRIPS Issues related to patent thickets Issues related to obviousness/ double patenting Issues related to FDA/PTO coordination Issues related to skinny labeling S.1041 A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1040 -A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S 708/ HR 1574 -- Realizing Engineering, Science and Technology Opportunities by Restoring Exclusive Patent Rights Act of 2025 (RESTORE) S.1553/HR3160-- Promoting and Respecting Economically Viable American Innovation Act (PREVAIL) S. 1546/ HR 3152-- Patent Eligibility Restoration Act of 2025 (PERA) S 2276 / HR 3269 Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 43/HR 6485 Skinny Labels Big Savings Act S.2658 Medication Affordability and Patent Integrity Act S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025

Client expense: $2,580,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to tariffs Issues related to trade agreements S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025

Client expense: $2,580,000 · Firm income: Not reported

H.R.6624/S.3452 - Biological Intellectual Property Protection Act of 2025

Client expense: Not reported · Firm income: $82,500

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)

H.R.6624/S.3452 - Biological Intellectual Property Protection Act of 2025 Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Robotics and Industrial Machinery (Docket No. 250924-0161 / XRIN 0694-XC138)

Client expense: Not reported · Firm income: $75,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE